| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles |
From the First Department of Internal Medicine, National Defense Medical College, Tokorozawa, Saitama, Japan.
Correspondence to Hiroshi Yoshida, MD. From June 1, 1996, through April 30, 1998: c/o Daniel Steinberg, MD, PhD, Room 1080, Department 0682, Basic Science Bldg, Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093-0682; after May 1, 1998: First Department of Internal Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359, Japan.
Abstract The presence of conventional risk factors cannot sufficiently account for the excess risk of atherosclerosis in patients with noninsulin-dependent diabetes mellitus (NIDDM). Oxidative modification of LDL has been implicated in the pathogenesis of coronary atherosclerosis. Thirty-five patients with NIDDM, 20 nondiabetic, hypertriglyceridemic subjects (HTG-control), and 21 diabetic, normotriglyceridemic subjects (NTG-control) were enrolled in this study. Oxidative susceptibility of LDL was determined by monitoring formation of conjugated dienes. Mean lag time of LDL oxidation and vitamin E/lipid peroxide of LDL was lower in patients with NIDDM (43.2±3.9 minutes and 1.6±1.3) than in HTG-control (48.8±3.2 minutes and 2.3±1.2, respectively) and NTG-control subjects (54.2±6.1 minutes and 3.0±1.8, respectively). Mean LDL particle size in patients with NIDDM and HTG-control subjects (24.4±0.9 and 24.7±0.7 nm, respectively) was smaller than in NTG-control subjects (25.9±1.0 nm). Multiple stepwise regression analyses ascertained that the vitamin E/lipid peroxide of LDL is a major determinant of LDL oxidation lag time. These results suggest that LDL in patients with NIDDM is more susceptible to oxidative modification primarily because of a reduced level of vitamin E/lipid peroxide of LDL. The enhanced susceptibility of LDL to oxidation may be a pivotal factor underlying the increased incidence of vascular disease in patients with NIDDM.
Key Words: oxidative susceptibility LDL lipid peroxide vitamin E noninsulin-dependent diabetes mellitus
This article has been cited by other articles:
![]() |
J. E. Barbato, B. S. Zuckerbraun, M. Overhaus, K. G. Raman, and E. Tzeng Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H228 - H236. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Devaraj, S. V. Hirany, R. F. Burk, and I. Jialal Divergence between LDL Oxidative Susceptibility and Urinary F2-Isoprostanes as Measures of Oxidative Stress in Type 2 Diabetes Clin. Chem., November 1, 2001; 47(11): 1974 - 1979. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haidari, E. Javadi, M. Kadkhodaee, and A. Sanati Enhanced Susceptibility to Oxidation and Diminished Vitamin E Content of LDL from Patients with Stable Coronary Artery Disease Clin. Chem., July 1, 2001; 47(7): 1234 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Davi, G. Ciabattoni, A. Consoli, A. Mezzetti, A. Falco, S. Santarone, E. Pennese, E. Vitacolonna, T. Bucciarelli, F. Costantini, et al. In Vivo Formation of 8-Iso-Prostaglandin F2{alpha} and Platelet Activation in Diabetes Mellitus : Effects of Improved Metabolic Control and Vitamin E Supplementation Circulation, January 19, 1999; 99(2): 224 - 229. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |